Bavarian Nordic (OTCMKTS:BVNRY) Posts Quarterly Earnings Results

Bavarian Nordic (OTCMKTS:BVNRY) announced its quarterly earnings results on Friday. The company reported $0.72 earnings per share for the quarter, Zacks reports. Bavarian Nordic had a net margin of 21.95% and a return on equity of 12.35%.

Bavarian Nordic Stock Performance

BVNRY traded down $0.57 during trading on Friday, reaching $9.09. 4,654 shares of the company traded hands, compared to its average volume of 6,711. The company has a market cap of $2.16 billion, a P/E ratio of 10.45 and a beta of 1.23. Bavarian Nordic has a 12-month low of $6.60 and a 12-month high of $13.00. The firm has a fifty day simple moving average of $11.86 and a 200 day simple moving average of $10.60.

About Bavarian Nordic

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.